300142 沃森生物
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(20,239)490,9261,036,5251,133,7691,201,491
投资活动产生之现金流量净额(138,228)(316,649)(1,266,667)(807,994)(935,186)
筹资活动产生之现金流量净额(223,006)(2,584,184)(371,031)236,64494,818
汇率变动对现金及现金等价物的影响(1,147)(952)5,4132,2754,069
现金及现金等价物净增加/(减少)(382,620)(2,410,859)(595,760)564,694365,192
期初现金及现金等价物余额1,348,2443,759,1034,354,8633,790,1693,424,977
期末现金及现金等价物余额965,6241,348,2443,759,1034,354,8633,790,169